Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02509689 · ClinicalTrials.gov registry record · NA

Neurofeedback Technology (GZNT) for Persistent Post-Concussive Symptoms in Soldiers

A NA study, sponsored by The Defense and Veterans Brain Injury Center.

Completed
Registry status
NA
Development phase
172
Enrollment target

NCT02509689 is a NA study that has completed, run by The Defense and Veterans Brain Injury Center. The registered enrollment target is 172 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02509689, a NA study, has completed, sponsored by The Defense and Veterans Brain Injury Center.

COMPLETED
Registry status
NA
Development phase
172 participants
Enrollment target

Study Summary

A new technology called Global Z-Score Neurofeedback Technology (GZNT) has been identified that can overcome an existing barrier to the use of neurofeedback as a treatment technique in a military setting. Neurofeedback, or EEG Biofeedback, is a form of biofeedback that uses the brain's own electrical activity as the training parameter. With sufficient practice, the brain can learn to change its own activity through finely tuned feedback using computerized sounds, graphs and animations. Previous attempts at using neurofeedback as a treatment modality have been subject to a lack of standardization and have required significant expertise on the part of the provider. This new GZNT technology allows neurofeedback to be administered in a standardized and semi-automated fashion, which, if effective, will represent a significant advance toward providing this promising treatment modality to Service Members in a military or VA setting. This study will determine feasibility and preliminary evidence of efficacy for this neurofeedback technology in a pilot study of soldiers with medical issues associated with Traumatic Brain Injury (TBI). GZNT technology has the potential to provide a cost-efficient, non-invasive/non-pharmacological approach to recovery from impact and/or blast-induced brain injury, and holds promise to simultaneously address emotional symptoms that are often a part of the post-concussion symptom picture.

Interventions

  • BEHAVIORAL Global Z-Score Neurofeedback Training

Trial Details

FieldValue
Enrollment Target 172 participants
Start Date 2014-12
Est. Completion 2022-03
Phase NA

What the Registry Record Tells You About NCT02509689

The ClinicalTrials.gov registry entry for NCT02509689 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 172 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Defense and Veterans Brain Injury Center, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Global Z-Score Neurofeedback Training is the first listed.

NCT02509689 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02509689 about?

NCT02509689 is a clinical study titled "Neurofeedback Technology (GZNT) for Persistent Post-Concussive Symptoms in Soldiers". A new technology called Global Z-Score Neurofeedback Technology (GZNT) has been identified that can overcome an existing barrier to the use of neurofeedback as a treatment technique in a military setting. Neurofeedback, or EEG Biofeedback, is a form of biofeedback that uses the brain's own electrica...

What is the current status of trial NCT02509689?

This trial is currently completed. It is a NA study. The enrollment target is 172 participants. The study started on 2014-12. Estimated completion is 2022-03.

What interventions are being tested in trial NCT02509689?

The interventions under investigation include: Global Z-Score Neurofeedback Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT02509689?

This trial is sponsored by The Defense and Veterans Brain Injury Center, which has 3 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.